Funding of 19.96M SEK to conduct an RCT of Montelukast for treating Parkinson’s disease has been awarded to the group. Link for more information can be found here.
Translational Research on Neuropharmacology and Movement Disorders
Funding of 19.96M SEK to conduct an RCT of Montelukast for treating Parkinson’s disease has been awarded to the group. Link for more information can be found here.